Sunshine Biopharma Inc.
- Last sale
- Nov 12, 2026 · +5.19%
- Market cap
- $2.42M
- 823.77K shares
- Filings
- 432
Q3 2026+4.1% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q2 2026derivedN/M FY25 yoy
Q3 2025N/M FY24 yoy
Q3 2026−5.8% FY25 yoy
- $2.42M
- —
- 0.1×
- 0.1×
- —
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $36,305,891 | reported | |
| FY 2024 | 2024-12-31 | $34,874,283 | reported | |
| FY 2023 | 2023-12-31 | $24,092,787 | reported | |
| FY 2022 | 2022-12-31 | $4,345,603 | reported | |
| FY 2021 | 2021-12-31 | $228,426 | reported | |
| FY 2020 | 2020-12-31 | $71,410 | reported | |
| FY 2019 | 2019-12-31 | $21,121 | reported | |
| FY 2018 | 2018-12-31 | $0 revised | reported | |
| FY 2017 | 2017-12-31 | $0 | reported | |
| FY 2016 | 2016-12-31 | $0 | reported | |
| FY 2015 | 2015-12-31 | $1,708 | reported | |
| FY 2014 | 2014-12-31 | $0 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | — | $0.00 | $0.00 | — | 4.91M sh | +81.2% | — |
| FY2024 | — | $3.14M | $3.14M | — | 2.71M sh | −97.3% | — |
| FY2023 | — | $541.14K | $541.14K | — | 99.45M sh | +340.3% | — |
Pharmaceutical preparations
Sunshine Biopharma Inc. is the 140th largest of the 554 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
BFRIBiofrontera Inc.$41.7M11.7%25.3%$14.0MBGMBGM Group Ltd.$37.9M51.1%52.6%—LIFDLFTD Partners Inc.$36.9M1.1%67.3%$3.7M
SBFMSunshine Biopharma Inc. (this company)$36.3M4.1%16.5%$2.4M
ETSTEarth Science Tech, Inc.$35.7M7.8%10.2%$25.9MVRCAVerrica Pharmaceuticals Inc.$35.6M370.2%50.3%$52.9MBHSTBioharvest Sciences Inc.$34.5M37.0%32.3%$39.7MZOMDFZomedica Corp.$32.0M17.4%255.6%$78.4MVSTMVerastem, Inc.$30.9M209.1%677.6%$1.1BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Sunshine Biopharma Inc. · CIK 1402328 · Engraved from SEC EDGAR